Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Bauernhofer Thomas |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2023
Originalarbeit (Zeitschrift)
** Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T
Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
Clin Genitourin Cancer. 2023; 21(1):24-31
Doi: 10.1016/j.clgc.2022.10.005
Web of Science
PubMed
FullText
FullText_MUG
2022
Originalarbeit (Zeitschrift)
** Barth, DA; Stanzer, S; Spiegelberg, J; Bauernhofer, T; Absenger, G; Posch, F; Lipp, R; Halm, M; Szkandera, J; Balic, M; Gerger, A; Smolle, MA; Hutterer, GC; Klec, C; Jost, PJ; Kargl, J; Stradner, M; Pichler, M
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study.
Cancer Med. 2022; 11(16):3074-3083
Doi: 10.1002/cam4.4675
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Barth, DA; Stanzer, S; Spiegelberg, JA; Bauernhofer, T; Absenger, G; Szkandera, J; Gerger, A; Smolle, MA; Hutterer, GC; Ahyai, SA; Madl, T; Posch, F; Riedl, JM; Klec, C; Jost, PJ; Kargl, J; Stradner, MH; Pichler, M
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study.
Front Immunol. 2022; 13: 840207
Doi: 10.3389/fimmu.2022.840207
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Fluhrer, H; Hutterer, GC; Golbeck, S; Stidl, M; Niedrist, T; Pichler, R; Mischinger, J; Seles, M; Mannweiler, S; Spiegelberg, J; Bauernhofer, T; Jost, PJ; Ahyai, S; Zigeuner, R; Pichler, M; Barth, DA
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.
Ther Adv Med Oncol. 2022; 14: 17588359221134065
Doi: 10.1177/17588359221134065
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Gampenrieder, SP; Pircher, M; Fesl, C; Rinnerthaler, G; Mlineritsch, B; Greil-Ressler, S; Steger, GG; Sagaster, V; Fitzal, F; Exner, R; Devyatko, Y; Balic, M; Stöger, H; Suppan, C; Bauernhofer, T; Singer, CF; Pfeiler, G; Seifert, M; Helfgott, R; Heck, D; Rumpold, H; Kwasny, W; Wieder, U; Gnant, M; Greil, R
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Breast Care (Basel). 2022; 17(2):137-145
Doi: 10.1159/000516157
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Maisel, F; Smolle, MA; Mollnar, S; Riedl, JM; Barth, DA; Seles, M; Terbuch, A; Rossmann, CH; Eisner, F; Mannweiler, S; Hutterer, G; Zigeuner, R; Pummer, K; Smolle-Jüttner, FM; Lindenmann, J; Stotz, M; Gerger, A; Jost, PJ; Bauernhofer, T; Pichler, M; Posch, F
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis.
Clin Genitourin Cancer. 2022; 20(4):344-353
Doi: 10.1016/j.clgc.2022.03.010
Web of Science
PubMed
FullText
FullText_MUG
** Pelzmann, B; Hatab, A; Scheruebel, S; Langthaler, S; Rienmueller, T; Sokolowski, A; Gorischek, A; Platzer, D; Zorn-Pauly, K; Jahn, SW; Bauernhofer, T; Schreibmayer, W
Consequences of somatic mutations of GIRK1 detected in primary malign tumors on expression and function of G-protein activated, inwardly rectifying, K+ channels
FRONT ONCOL. 2022; 12: 998907
Doi: 10.3389/fonc.2022.998907
Web of Science
FullText
FullText_MUG
** Terbuch, A; Posch, F; Bauernhofer, T; Jost, PJ; Partl, R; Stranzl-Lawatsch, H; Baciarello, G; Fizazi, K; Giannatempo, P; Verzoni, E; Sweeney, C; Ravi, P; Tran, B; Basso, U; White, J; Vincenzi, B; Oing, C; Cutuli, HJ; Dieckmann, KP; Gamulin, M; Chovanec, M; Fankhauser, CD; Heidenreich, A; Mohamad, O; Thibault, C; Fischer, S; Gillessen, S, , International, Germ, Cell, Cancer, Collaborative, Group
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2022; 113(4):825-832
Doi: 10.1016/j.ijrobp.2022.03.021
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T
Thromboprophylaxis and its influence on the risk of thromboembolism in patients with germ cell tumors receiving cisplatin-containing chemotherapy
ONCOL RES TREAT. 2022; 45(SUPPL 2):322-322.
[Poster]
Web of Science
2021
Originalarbeit (Zeitschrift)
** Barth, DA; Sareban, N; Lindner, AK; Daller, LAJ; Matzhold, EM; Hutterer, G; Smolle, M; Mischinger, J; Riedl, JM; Seles, M; Mannweiler, S; Bauernhofer, T; Pummer, K; Pichler, R; Zigeuner, R; Schlenke, P; Pichler, M
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Urol Oncol. 2021; 39(10):736.e9-736.e16
Doi: 10.1016/j.urolonc.2021.06.005
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gampenrieder, SP; Pircher, M; Fesl, C; Rinnerthaler, G; Mlineritsch, B; Greil-Ressler, S; Steger, GG; Sagaster, V; Fitzal, F; Exner, R; Devyatko, Y; Balic, M; Stoger, H; Suppan, C; Bauernhofer, T; Singer, CF; Pfeiler, G; Seifert, M; Helfgott, R; Heck, D; Rumpold, H; Kwasny, W; Wieder, U; Gnant, M; Greil, R
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
BREAST CARE. 2021;
Doi: 10.1159/000516157
Web of Science
FullText
FullText_MUG
** Gnant, M; Fitzal, F; Rinnerthaler, G; Steger, GG; Greil-Ressler, S; Balic, M; Heck, D; Jakesz, R; Thaler, J; Egle, D; Manfreda, D; Bjelic-Radisic, V; Wieder, U; Singer, CF; Melbinger-Zeinitzer, E; Haslbauer, F; Sevelda, P; Trapl, H; Wette, V; Wimmer, K; Gampenrieder, SP; Bartsch, R; Kacerovsky-Strobl, S; Suppan, C; Brunner, C; Deutschmann, C; Soelkner, L; Fesl, C; Greil, R, , Austrian, Breast, and, Colorectal, Cancer, Study, Group;Austrian, Breast, and, Colorectal, Cancer, Study, Group
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
N Engl J Med. 2021; 385(5):395-405
Doi: 10.1056/NEJMoa2104162
Web of Science
PubMed
FullText
FullText_MUG
** Riedl, JM; Hasenleithner, SO; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stöger, H; Berghold, A; Hoefler, G; Speicher, MR; Heitzer, E; Gerger, A
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
Ther Adv Med Oncol. 2021; 13:1758835920987658
Doi: 10.1177/1758835920987658
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Originalarbeit (Zeitschrift)
** Hofmann, L; Sallinger, K; Haudum, C; Smolle, M; Heitzer, E; Moser, T; Novy, M; Gesson, K; Kroneis, T; Bauernhofer, T; El-Heliebi, A
A Multi-Analyte Approach for Improved Sensitivity of Liquid Biopsies in Prostate Cancer.
Cancers (Basel). 2020; 12(8):
Doi: 10.3390/cancers12082247
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Klöckl, MC; Kasparek, AK; Riedl, JM; Moik, F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer, T; Schilcher, G; Zitta, S; Rosenkranz, AR; Friedl, C; Stöger, H; Posch, F
Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
Sci Rep. 2020; 10(1):11219
Doi: 10.1038/s41598-020-68010-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moritz, J; Bauernhofer, T; Mannweiler, S; Langsenlehner, T; Pummer, K; Dandachi, N; Pichler, M
Evaluation of Blood-based Biomarkers for Prediction of Response in Carboplatin-treated Metastatic Castration-resistant Prostate Cancer Patients.
In Vivo. 2020; 34(6): 3631-3638.
Doi: 10.21873/invivo.12209
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moser, T; Waldispuehl-Geigl, J; Belic, J; Weber, S; Zhou, Q; Hasenleithner, SO; Graf, R; Terzic, JA; Posch, F; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Heitzer, E; Geigl, JB; Bauernhofer, T; Speicher, MR
On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer.
NPJ Precis Oncol. 2020; 4(1):30
Doi: 10.1038/s41698-020-00134-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Seles, M; Hutterer, GC; Foßelteder, J; Svoboda, M; Resel, M; Barth, DA; Pichler, R; Bauernhofer, T; Zigeuner, RE; Pummer, K; Slaby, O; Klec, C; Pichler, M
Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer.
Cancers (Basel). 2020; 12(5): 1200
Doi: 10.3390/cancers12051200
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zhou, Q; Perakis, SO; Ulz, P; Mohan, S; Riedl, JM; Talakic, E; Lax, S; Tötsch, M; Hoefler, G; Bauernhofer, T; Pichler, M; Gerger, A; Geigl, JB; Heitzer, E; Speicher, MR
Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer.
Genome Med. 2020; 12(1):20
Doi: 10.1186/s13073-020-0719-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fallbericht
** Lembeck, AL; Puchas, P; Hutterer, G; Barth, DA; Terbuch, A; Bauernhofer, T; Pichler, M
MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients.
Noncoding RNA. 2020; 6(1):
Doi: 10.3390/ncrna6010002
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Korrektur
** Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, CES; John, JS; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher, MR
Publisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Nat Commun. 2020; 11(1): 1965-1965.
Doi: 10.1038/s41467-020-15799-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Andritsch, E; Farkas, C; Stanzer, S; Bauernhofer, T; Vigier, M
Psychoneuroimmunological predictors of breast cancer progression.
J PSYCHOSOM RES. 2020; 133: 110081-
Doi: 10.1016/j.jpsychores.2020.110081
Web of Science
FullText
FullText_MUG
** Bauernhofer, T; Stanzer, S; Prietl, B; Kofler, S; Obermayer-Pietsch, B; Pichler, M; Sourij, H; Pieber, T
Tregs cells - a double edged sword? Lessons learned from colorectal cancer in comparison to type 1 diabetes mellitus.
ONCOL RES TREAT. 2020; 43(SUPPL 4):127-128.
[Poster]
Web of Science
** Gerger, A; Riedl, JM; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E
Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial.
ANN ONCOL. 2020; 31: S1095-S1096.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.08.1331
[Onlinepräsentation]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Klec, C; Schwarzenbacher, D; Gottschalk, B; Margit, R; Prinz, F; Bauernhofer, T; Stoeger, H; Graier, WF; Pichler, M
Deciphering the interplay between nuclear RNA export factors and long non-coding RNAs in breast cancer metabolism.
ANN ONCOL. ESMO Breast Cancer Virtual Meeting 2020. 2020; 31(S2):S38-S38.-ESMO Breast Cancer Virtual Meeting; MAY 23-24, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.03.202
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Moser, T; Waldispuehl-Geigl, J; Belic, J; Perakis, S; Weber, S; Zhou, Q; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR
Early circulating tumor DNA dynamics as a real-time predictor of FOLFOX efficacy in advanced colorectal cancer patients
CANCER RES. 2020; 80(16):
Doi: 10.1158/1538-7445.AM2020-4295
[Poster]
Web of Science
FullText
FullText_MUG
** Riedl, J; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E; Gerger, A
Individualized cancer treatment based on molecular profiling of circulating tumor DNA in patients with advanced and refractory carcinoma: a prospective phase II trial.
ONCOL RES TREAT. 2020; 43(SUPPL 4):249-249.-DGHO Jahrestagung; 09.10. -11.10.2020; Basel (virtueller Kongress).
[Oral Communication]
Web of Science
2019
Originalarbeit (Zeitschrift)
** Moik, F; Riedl, JM; Winder, T; Terbuch, A; Rossmann, CH; Szkandera, J; Bauernhofer, T; Kasparek, AK; Schaberl-Moser, R; Reicher, A; Prinz, F; Pichler, M; Stöger, H; Stotz, M; Gerger, A; Posch, F
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.
Sci Rep. 2019; 9(1):5548
Doi: 10.1038/s41598-019-42069-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schmidinger, M; Pichler, R; Loidl, W; Bauernhofer, T; Kretz, M; Tinchon, C; Niedersüß-Beke, D; Pfleger, G; Wiesinger, CG; Vogl, U; Mitterberger, M; Stöger, H; Tulchiner, G; Kratochvill, F; Gerritsmann, H; Mraz, B; Marszalek, M
Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study.
Clin Genitourin Cancer. 2019; 17(5):e957-e967-e957-e967
Doi: 10.1016/j.clgc.2019.05.017
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schratter, G; Scheruebel, S; Langthaler, S; Ester, K; Pelzmann, B; Ghaffari-Tabrizi-Wizsy, N; Rezania, S; Gorischek, A; Platzer, D; Zorn-Pauly, K; Ahammer, H; Prokesch, A; Stanzer, S; Devaney, TTJ; Schmidt, K; Jahn, SW; Prassl, R; Bauernhofer, T; Schreibmayer, W;
GIRK1 triggers multiple cancer-related pathways in the benign mammary epithelial cell line MCF10A.
SCI REP. 2019; 9: 19277
Doi: 10.1038/s41598-019-55683-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schwarzenbacher, D; Klec, C; Pasculli, B; Cerk, S; Rinner, B; Karbiener, M; Ivan, C; Barbano, R; Ling, H; Wulf-Goldenberg, A; Stanzer, S; Rinnerthaler, G; Stoeger, H; Bauernhofer, T; Haybaeck, J; Hoefler, G; Jahn, SW; Parrella, P; Calin, GA; Pichler, M
MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.
Breast Cancer Res. 2019; 21(1): 20-20.
Doi: 10.1186/s13058-019-1104-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Singer, CF; Filipits, M; Jahn, SW; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Kastner, M; Schmitt, M; Moinfar, F; Gnant, M
Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
Breast. 2019; 46(14):101-107
Doi: 10.1016/j.breast.2019.05.007
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Terbuch, A; Posch, F; Bauernhofer, T; Pichler, M; Peinsith, H; Szkandera, J; Riedl, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Stotz, M; Gerger, A
Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.
Anticancer Res. 2019; 39(10):5589-5596
Doi: 10.21873/anticanres.13753
Web of Science
PubMed
FullText
FullText_MUG
** Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, CES; John, JS; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher, MR
Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Nat Commun. 2019; 10(1): 4666-4666.
Doi: 10.1038/s41467-019-12714-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Vehabovic-Delic, A; Balic, M; Rossmann, C; Bauernhofer, T; Deutschmann, HA; Schoellnast, H
Volume Computed Tomography Perfusion Imaging: Evaluation of the Significance in Oncologic Follow-up of Metastasizing Renal Cell Carcinoma in the Early Period of Targeted Therapy - Preliminary Results.
J Comput Assist Tomogr. 2019; 43(3):493-498
Doi: 10.1097/RCT.0000000000000848
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Niedersuss-Beke, D; Tinchon, C; Loidl, W; Pichler, M; Jahn, S; Stoger, H; Bauernhofer, T;
Lymphopenia impairs response to 1st-line tyrosine kinase inhibitor therapy in patients with metastatic clear-cell renal cell carcinoma and modulates the relative efficacy of sunitinib and pazopanib
WIEN KLIN WOCHENSCHR. 2019; 131: S447-S447.-Frühjahrstagung der OeGHO; APR 11-13, 2019; Linz, AUSTRIA.
[Poster]
Web of Science
FullText
2018
Originalarbeit (Zeitschrift)
** Belic, J; Graf, R; Bauernhofer, T; Cherkas, Y; Ulz, P; Waldispuehl-Geigl, J; Perakis, S; Gormley, M; Patel, J; Li, W; Geigl, JB; Smirnov, D; Heitzer, E; Gross, M; Speicher, MR
Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide.
Int J Cancer. 2018; 143(5): 1236-1248.
Doi: 10.1002/ijc.31397
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** El-Heliebi, A; Hille, C; Laxman, N; Svedlund, J; Haudum, C; Ercan, E; Kroneis, T; Chen, S; Smolle, M; Rossmann, C; Krzywkowski, T; Ahlford, A; Darai, E; von Amsberg, G; Alsdorf, W; König, F; Löhr, M; de Kruijff, I; Riethdorf, S; Gorges, TM; Pantel, K; Bauernhofer, T; Nilsson, M; Sedlmayr, P
In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells.
Clin Chem. 2018; 64(3):536-546
Doi: 10.1373/clinchem.2017.281295
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Stanzer, S; Andritsch, E; Zloklikovits, S; Ladinek, V; Farkas, C; Augustin, T; Obermayer-Pietsch, B; Samonigg, H; Bauernhofer, T
A Pilot Randomized Trial Assessing the Effect of a Psychoeducational Intervention on Psychoneuroimmunological Parameters Among Patients With Nonmetastatic Breast Cancer.
Psychosom Med. 2018; 81(2):165-175
Doi: 10.1097/PSY.0000000000000656
Web of Science
PubMed
FullText
FullText_MUG
** Terbuch, A; Adiprasito, JB; Stiegelbauer, V; Seles, M; Klec, C; Pichler, GP; Resel, M; Posch, F; Lembeck, AL; Stöger, H; Szkandera, J; Pummer, K; Bauernhofer, T; Hutterer, GC; Gerger, A; Stotz, M; Pichler, M
MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Int J Mol Sci. 2018; 19(10):
Doi: 10.3390/ijms19103130
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Terbuch, A; Posch, F; Partl, R; Zurl, B; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Kapp, KS; Stöger, H; Gerger, A; Stotz, M
Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.
Cancer Med. 2018; 7(2):508-514
Doi: 10.1002/cam4.1317
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Belic, J; Graf, R; Bauernhofer, T; Cherkas, Y; Peter, U; Waldispuehl-Geigl, J; Perakis, S; Gormley, M; Patel, J; Li, WM; Geigl, JB; Smirnov, D; Heitzer, E; Gross, M; Speicher, MR
Analysis of circulating tumor DNA reveals genomic alterations in metastatic prostate cancer patients treated with abiraterone acetate plus prednisone or enzalutamide
CANCER RES. 2018; 78(13):-Annual Meeting of the American-Association-for-Cancer-Research (AACR); APR 14-18, 2018; Chicago, IL.
Doi: 10.1158/1538-7445.AM2018-2959
[Oral Communication]
Web of Science
FullText
FullText_MUG
Abstract (Konferenzband)
** Klöckl, MC; Kasparek, AK; Riedl, J; Moik ,F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer T; Stöger H; Posch, F
Estimated versus measured glomerular filtration rate to
evaluate kidney function in patients with cancer undergoing
cisplatin-based chemotherapy
Oncology Research
and Treatment . 2018; 41(Suppl4):224-224.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 )
[Poster]
Web of Science
FullText
** Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Pichler, M; Jahn, S; Stöger, H; Bauernhofer, T
Lymphopenia impairs response to 1st-line therapy with
sunitinib and pazopanib in patients with metastatic clear-cell
renal cell carcinoma.
Oncology Research
and Treatment . 2018; 41(Suppl4):42-43.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie,; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 )
[Oral Communication]
Web of Science
FullText
2017
Originalarbeit (Zeitschrift)
** Balic, M; Bartsch, R; Bauernhofer, T; Vrbanec, D; Vrdoljak, E
Biosimilars in the Treatment of Breast Cancer.
Breast Care (Basel). 2017; 12(3):192-194
Doi: 10.1159/000477926
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M
Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.
PLoS One. 2017; 12(4):e0176283-e0176283
Doi: 10.1371/journal.pone.0176283
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Terbuch, A; Posch, F; Annerer, LM; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Gerger, A; Stotz, M
Long-term cardiovascular complications in stage I seminoma patients.
Clin Transl Oncol. 2017; 19(11):1400-1408
Doi: 10.1007/s12094-017-1742-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Smolle, MA; Bauernhofer, T; Pummer, K; Calin, GA; Pichler, M
Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
Int J Mol Sci. 2017; 18(2):
Doi: 10.3390/ijms18020473
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Bauernhofer, T
Molecular subtypes and predictive markers
ONCOL RES TREAT. 2017; 40: 100-100.-Jahrestagung der DGHO, OeGHO, SGMO, SGH; SEP 29-OCT 3, 2017; Stuttgart, Germany.
[Oral Communication]
Web of Science
** Bezan, A; Pasch, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Zurl, B; Kapp, K; Stager, H; Gerger, A; Stotz, M
Clinical characterization of febrile neutropenia episodes in patients with testicular germ cell tumors.
J CLIN ONCOL. 2017; 35: -53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET; JUN 02-07, 2017; Chicago, IL.
Doi: 10.1200/JCO.2017.35.15_suppl.e16038
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Schmidinger, M; Pichler, R; Bauernhofer, T; Kretz, M; Tinchon, C; Niedersuss-Beke, D; Pfleger, G; Heinrich, E; Vogl, U; Mitterberger, M; Stoger, H; Tulchiner, G; Kratochvill, F; Mraz, B; Marszalek, M
Real-world evidence data on aRCC treatment in Austria: the RELACS study
ONCOL RES TREAT. 2017; 40: 276-276.-Jahrestagung der DGHO, OeGHO, SGMO, SGH; SEP 29-OCT 3, 2017; Stuttgart, Germany.
[Oral Communication]
Web of Science
2016
Originalarbeit (Zeitschrift)
** Belic, J; Koch, M; Ulz, P; Auer, M; Gerhalter, T; Mohan, S; Fischereder, K; Petru, E; Bauernhofer, T; Geigl, JB; Speicher, MR; Heitzer, E
mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA.
Adv Exp Med Biol. 2016; 924:147-155
Doi: 10.1007/978-3-319-42044-8_28
Web of Science
PubMed
FullText
FullText_MUG
** Kammerer, S; Jahn, SW; Winter, E; Eidenhammer, S; Rezania, S; Regitnig, P; Pichler, M; Schreibmayer, W; Bauernhofer, T
Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry.
J Clin Pathol. 2016; 69(12):1116-1121
Doi: 10.1136/jclinpath-2016-203798
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Jahn, SW; El-Heliebi, A; Schwarzenbacher, D; Stiegelbauer, V; Pichler, M; Rezania, S; Fiegl, H; Peintinger, F; Regitnig, P; Hoefler, G; Schreibmayer, W; Bauernhofer, T
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients.
Oncotarget. 2016; 7(51):84705-84717
Doi: 10.18632/oncotarget.13224
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pehserl, AM; Ress, AL; Stanzer, S; Resel, M; Karbiener, M; Stadelmeyer, E; Stiegelbauer, V; Gerger, A; Mayr, C; Scheideler, M; Hutterer, GC; Bauernhofer, T; Kiesslich, T; Pichler, M
Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.
Int J Mol Sci. 2016; 17(12):
Doi: 10.3390/ijms17122011
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rezania, S; Kammerer, S; Li, C; Steinecker-Frohnwieser, B; Gorischek, A; DeVaney, TT; Verheyen, S; Passegger, CA; Tabrizi-Wizsy, NG; Hackl, H; Platzer, D; Zarnani, AH; Malle, E; Jahn, SW; Bauernhofer, T; Schreibmayer, W
Overexpression of KCNJ3 gene splice variants affects vital parameters of the malignant breast cancer cell line MCF-7 in an opposing manner.
BMC Cancer. 2016; 16(1):628-628
Doi: 10.1186/s12885-016-2664-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ulz, P; Belic, J; Graf, R; Auer, M; Lafer, I; Fischereder, K; Webersinke, G; Pummer, K; Augustin, H; Pichler, M; Hoefler, G; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.
Nat Commun. 2016; 7(15):12008-12008
Doi: 10.1038/ncomms12008
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Belic, J; Heitzer, E; Ulz, P; Auer, M; Fischereder, K; Bauernhofer, T; Geigl, JB; Speicher, MR
Analysis of ctDNA using the mFastSeqS and plasma-Seq methods for screening and therapy monitoring in prostate cancer patients
CLIN CANCER RES. 2016; 22: -Meeting of the American-Association-for-Cancer-Research (AACR) Precision Medicine Series - Integrating Clinical Genomics and Cancer Therapy; JUN 13-16, 2015; Salt Lake, UT.
Doi: 10.1158/1557-3265.PMSCLINGEN15-PR05
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Singer, CF; Filipits, M; Jahn, S; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Schmitt, M; Moinfar, F; Gnant, M
Stromel co-expression of urokinase-type plasminogen activator (uPA) and plasminogen activator Inhibitor (PAI-1) protein by IHC predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer
CANCER RES. 2016; 76: -38th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 08-12, 2015; San Antonio, TX.
Doi: 10.1158/1538-7445.SABCS15-P2-08-21
[Poster]
Web of Science
FullText
FullText_MUG
2015
Originalarbeit (Zeitschrift)
** Belic, J; Koch, M; Ulz, P; Auer, M; Gerhalter, T; Mohan, S; Fischereder, K; Petru, E; Bauernhofer, T; Geigl, JB; Speicher, MR; Heitzer, E
Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach.
Clin Chem. 2015; 61(6):838-849
Doi: 10.1373/clinchem.2014.234286
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Li, C; Rezania, S; Kammerer, S; Sokolowski, A; Devaney, T; Gorischek, A; Jahn, S; Hackl, H; Groschner, K; Windpassinger, C; Malle, E; Bauernhofer, T; Schreibmayer, W
Piezo1 forms mechanosensitive ion channels in the human MCF-7 breast cancer cell line.
Sci Rep. 2015; 5(2):8364-8364
Doi: 10.1038/srep08364
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ress, AL; Stiegelbauer, V; Winter, E; Schwarzenbacher, D; Kiesslich, T; Lax, S; Jahn, S; Deutsch, A; Bauernhofer, T; Ling, H; Samonigg, H; Gerger, A; Hoefler, G; Pichler, M
MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients.
Mol Carcinog. 2015; 54(11):1442-1450
Doi: 10.1002/mc.22218
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Ludwig, H; Evstatiev, R; Kornek, G; Aapro, M; Bauernhofer, T; Buxhofer-Ausch, V; Fridrik, M; Geissler, D; Geissler, K; Gisslinger, H; Koller, E; Kopetzky, G; Lang, A; Rumpold, H; Steurer, M; Kamali, H; Link, H
Iron metabolism and iron supplementation in cancer patients.
Wien Klin Wochenschr. 2015; 127(23-24):907-919
Doi: 10.1007/s00508-015-0842-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Korrektur
** Ludwig, H; Evstatiev, R; Kornek, G; Aapro, M; Bauernhofer, T; Buxhofer-Ausch, V; Fridrik, M; Geissler, D; Geissler, K; Gisslinger, H; Koller, E; Kopetzky, G; Lang, A; Rumpold, H; Steurer, M; Kamali, H; Link, H
Iron metabolism and iron supplementation in cancer patients (vol 127, pg 907, 2015)
WIEN KLIN WOCHENSCHR. 2015; 127(23-24): 920-921.
Doi: 10.1007/s00508-015-0893-5
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Abstract (Zeitschrift)
** Heitzer, E; Ulz, P; Auer, M; Belic, J; Sumitra, M; Lax, S; Hoefler, G; Augustin, H; Edgar, P; Bauernhofer, T; Geigl, J; Speicher, M
Clinical utility of circulating tumor DNA in human cancers: A report of more than 300 plama-Seqs
EUR J CANCER. 2015; 51: S33-S33.-European Cancer Congress; Sep 25-29, 2015; Vienna, AUSTRIA.
Doi: 10.1016/S0959-8049(16)30108-3
[Poster]
Web of Science
FullText
FullText_MUG
** Singer, CF; Filipits, M; Jahn, S; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Schmitt, M; Moinfar, F; Gnant, M
Influence of immunohistological detection of intratumoral urokinase-type plasminogen activator (uPA) on disease outcome in endocrine-treated postmenopausal patients with hormone receptor-positive early breast cancer.
J CLIN ONCOL. 2015; 33(15):
Doi: 10.1200/jco.2015.33.15_suppl.551
[Poster]
Web of Science
FullText
FullText_MUG
2014
Originalarbeit (Zeitschrift)
** Aigelsreiter, AM; Aigelsreiter, A; Wehrschuetz, M; Ress, AL; Koller, K; Salzwimmer, M; Gerger, A; Schauer, S; Bauernhofer, T; Pichler, M
Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer.
Hum Pathol. 2014; 45(4):683-690
Doi: 10.1016/j.humpath.2013.11.014
Web of Science
PubMed
FullText
FullText_MUG
** Brämswig, K; Ploner, F; Martel, A; Bauernhofer, T; Hilbe, W; Kühr, T; Leitgeb, C; Mlineritsch, B; Petzer, A; Seebacher, V; Stöger, H; Girschikofsky, M; Hochreiner, G; Ressler, S; Romeder, F; Wöll, E; Brodowicz, T
Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.
Anticancer Drugs. 2014; 25(7):848-853
Doi: 10.1097/CAD.0000000000000108
Web of Science
PubMed
FullText
FullText_MUG
** Filipits, M; Nielsen, TO; Rudas, M; Greil, R; Stöger, H; Jakesz, R; Bago-Horvath, Z; Dietze, O; Regitnig, P; Gruber-Rossipal, C; Müller-Holzner, E; Singer, CF; Mlineritsch, B; Dubsky, P; Bauernhofer, T; Hubalek, M; Knauer, M; Trapl, H; Fesl, C; Schaper, C; Ferree, S; Liu, S; Cowens, JW; Gnant, M; Austrian Breast and Colorectal Cancer Study Group
The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.
Clin Cancer Res. 2014; 20(5):1298-1305
Doi: 10.1158/1078-0432.CCR-13-1845
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mohan, S; Heitzer, E; Ulz, P; Lafer, I; Lax, S; Auer, M; Pichler, M; Gerger, A; Eisner, F; Hoefler, G; Bauernhofer, T; Geigl, JB; Speicher, MR
Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.
PLoS Genet. 2014; 10(3):e1004271-e1004271
Doi: 10.1371/journal.pgen.1004271
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pichler, M; Ress, AL; Winter, E; Stiegelbauer, V; Karbiener, M; Schwarzenbacher, D; Scheideler, M; Ivan, C; Jahn, SW; Kiesslich, T; Gerger, A; Bauernhofer, T; Calin, GA; Hoefler, G
MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients.
Br J Cancer. 2014; 110(6):1614-1621
Doi: 10.1038/bjc.2014.51
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pichler, M; Winter, E; Ress, AL; Bauernhofer, T; Gerger, A; Kiesslich, T; Lax, S; Samonigg, H; Hoefler, G
miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.
J Clin Pathol. 2014; 67(3):198-203
Doi: 10.1136/jclinpath-2013-201904
Web of Science
PubMed
FullText
FullText_MUG
** Rogen, S; Hofmann, P; Bauernhofer, T; Müller, W
Evaluation of the physical activity biography: sport and transport.
J Sports Sci Med. 2014; 13(2):338-348
[OPEN ACCESS]
Web of Science
PubMed
Übersichtsarbeit
** Aigner, B; Bauernhofer, T; Petru, E; Niederkorn, A; Arzberger, EJ; Richtig, E
Complete recovery of a wide local reaction by the use of dexrazoxane 72 hours after epirubicin extravasation: case report and review of the literature.
Dermatology. 2014; 229(4):288-292
Doi: 10.1159/000365391
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Heitzer, E; Mohan, S; Ulz, P; Lafer, I; Auer, M; Lax, S; Hoefler, G; Bauernhofer, T; Geigl, JB; Speicher, MR;
Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.
EUR J CANCER. 2014; 50: S96-S96.-EACR 2014; München.
Doi: 10.1016/S0959-8049(14)50357-7
[Poster]
Web of Science
FullText
FullText_MUG
** Kammerer, S; Sokolowski, A; Hackl, H; Jahn, S; Asslaber, M; Symmans, F; Peintinger, F; Regitnig, P; Schreibmayer, W; Bauernhofer, T
OVEREXPRESSION OF G PROTEIN-ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL 1 (GIRK1) IS ASSOCIATED WITH LYMPH NODE METASTASIS AND POOR PROGNOSIS IN BREAST CANCER
ANN ONCOL. . 2014; 25: -IMPAKT Breast Cancer Conference; MAY 08-10, 2014; Brussels, BELGIUM.
Doi: 10.1093/annonc/mdu066.21
[Poster]
Web of Science
FullText
FullText_MUG
** Li, CY; Rezania, S; Kammerer, S; Gorischek, A; Bauernhofer, T; Schreibmayer, W
Mechano-Sensitive Ion Channels (MSCS) Provide Human Breast Cancer Cells with a Sensorium for Mechanical Stress.
BIOPHYS J. 2014; 106(2):549A-550A.-58th Annual Meeting of the Biophysical-Society; FEB 15-19, 2014; San Francisco, CA.
Doi: 10.1016/j.bpj.2013.11.3061
[Poster]
Web of Science
FullText
FullText_MUG
** Rezania, S; Li, CY; Kammerer, S; Gorischek, A; Devaney, T; Zarnani, AH; Bauernhofer, T; Schreibmayer, W;
G-Protein Activated Inwardly Rectifying Potassium Channels Control Motility of Breast Cancer Cells.
BIOPHYS J. 2014; 106(2):543A-543A.-58th Annual Meeting of the Biophysical-Society; FEB 15-19, 2014; San Francisco, CA.
Doi: 10.1016/j.bpj.2013.11.3026
[Poster]
Web of Science
FullText
FullText_MUG
2013
Originalarbeit (Zeitschrift)
** Andritsch, E; Stöger, H; Bauernhofer, T; Andritsch, H; Kasparek, AK; Schaberl-Moser, R; Ploner, F; Samonigg, H
The ethics of space, design and color in an oncology ward.
Palliat Support Care. 2013; 11(3):215-221
Doi: 10.1017/S1478951512000077
Web of Science
PubMed
FullText
FullText_MUG
** Gasch, C; Bauernhofer, T; Pichler, M; Langer-Freitag, S; Reeh, M; Seifert, AM; Mauermann, O; Izbicki, JR; Pantel, K; Riethdorf, S
Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer.
Clin Chem. 2013; 59(1):252-260
Doi: 10.1373/clinchem.2012.188557
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Heitzer, E; Auer, M; Gasch, C; Pichler, M; Ulz, P; Hoffmann, EM; Lax, S; Waldispuehl-Geigl, J; Mauermann, O; Lackner, C; Höfler, G; Eisner, F; Sill, H; Samonigg, H; Pantel, K; Riethdorf, S; Bauernhofer, T; Geigl, JB; Speicher, MR
Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.
Cancer Res. 2013; 73(10):2965-2975
Doi: 10.1158/0008-5472.CAN-12-4140
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Heitzer, E; Auer, M; Hoffmann, EM; Pichler, M; Gasch, C; Ulz, P; Lax, S; Waldispuehl-Geigl, J; Mauermann, O; Mohan, S; Pristauz, G; Lackner, C; Höfler, G; Eisner, F; Petru, E; Sill, H; Samonigg, H; Pantel, K; Riethdorf, S; Bauernhofer, T; Geigl, JB; Speicher, MR
Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer.
Int J Cancer. 2013; 133(2):346-356
Doi: 10.1002/ijc.28030
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hofmann, G; Balic, M; Dandachi, N; Resel, M; Schippinger, W; Regitnig, P; Samonigg, H; Bauernhofer, T
The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.
Clin Biochem. 2013; 46(15):1585-1589
Doi: 10.1016/j.clinbiochem.2013.06.010
Web of Science
PubMed
FullText
FullText_MUG
** Pirker-Frühauf, UM; Friesenbichler, J; Rabitsch, K; Liegl-Atzwanger, B; Bauernhofer, T; Windhager, R; Leithner, A
Three Metachronous Osteosarcomas within 22 Years without Pulmonary Metastases: A Case Report and Review of the Literature.
Case Rep Orthop. 2013; 2013(6):197287-197287
Doi: 10.1155/2013/197287
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Tinchon, C; Hubmann, E; Pichler, A; Keil, F; Pichler, M; Rabl, H; Uggowitzer, M; Jilek, K; Leitner, G; Bauernhofer, T
Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma.
Acta Oncol. 2013; 52(6):1231-1233
Doi: 10.3109/0284186X.2013.771821
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Aigelsreiter, AM; Aigelsreiter, A; Wehrschuetz, M; Ress, A; Koller, K; Kiesslich, T; Schauer, S; Bauernhofer, T; Pichler, M;
Reduced Expression of the Putative Tumour Suppressor Spinophilin Is an Adverse Prognostic Factor in Squamous Cell Carcinoma of the Head and Neck.
MODERN PATHOL. . 2013; 26(S2):301A-301A.-102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); MAR 02-08, 2013; Baltimore, MD.
[Poster]
Web of Science
** Aigelsreiter, AM; Aigelsreiter, A; Wehrschuetz, M; Ress, A; Koller, K; Kiesslich, T; Schauer, S; Bauernhofer, T; Pichler, M
Reduced Expression of the Putative Tumour Suppressor Spinophilin Is an Adverse Prognostic Factor in Squamous Cell Carcinoma of the Head and Neck.
LAB INVEST. . 2013; 93(S1):301A-301A.-102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); MAR 02-08, 2013; Baltimore, MD.
[Poster]
Web of Science
** Andritsch, E; Farkas, C; Zloklikovits,S; Samonigg, H;Bauernhofer,T
Hope and Optimism - The Additional Benefit for Patients With Cancer in the Interdisciplinary Treatment - From the Perspective of Psychoneuroimmunology.
PSYCHO-ONCOL. 2013; 22: 175-176.-15th World Congress of Psychooncology, Innovation in Psychooncology, clinical care- research-advocacy; NOV 4-8, 2013; Rotterdam, Netherlands.
[Poster]
Web of Science
** Bauernhofer, T
Is there an overall survival benefit with regard to additional treatment options in the sequential therapy of patients with metastatic renal cell cancer?
ONKOLOGIE. 2013; 36: 202-202.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; Oct 18-22, 2013; Wien.
[Oral Communication]
Web of Science
2012
Originalarbeit (Zeitschrift)
** Aigelsreiter, A; Haybaeck, J; Schauer, S; Kiesslich, T; Bettermann, K; Griessbacher, A; Stojakovic, T; Bauernhofer, T; Samonigg, H; Kornprat, P; Lackner, C; Pichler, M
NEMO expression in human hepatocellular carcinoma and its association with clinical outcome.
Hum Pathol. 2012; 43(7):1012-1019
Doi: 10.1016/j.humpath.2011.08.009
Web of Science
PubMed
FullText
FullText_MUG
** Rainer, PP; Doleschal, B; Kirk, JA; Sivakumaran, V; Saad, Z; Groschner, K; Maechler, H; Hoefler, G; Bauernhofer, T; Samonigg, H; Hutterer, G; Kass, DA; Pieske, B; von, Lewinski, D; Pichler, M
Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes.
BJU Int. 2012; 110(10):1455-62
Doi: 10.1111/j.1464-410X.2012.11134.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rauchenwald, M; Bauernhofer, T; De Santis, M; Füreder, T; Höltl, W; Kramer, G; Krause, S; Loidl, W; Oismüller, R; Reissigl, A; Schmeller, N; Stackl, W; Stoiber, F; Krainer, M
Treatment of castration refractory Prostate cancer.
Wien Klin Wochenschr. 2012; 124(15-16):538-551
Doi: 10.1007/s00508-012-0206-1
Web of Science
PubMed
FullText
FullText_MUG
2011
Originalarbeit (Zeitschrift)
** Bauernhofer, T; Pichler, M; Wieckowski, E; Stanson, J; Aigelsreiter, A; Griesbacher, A; Groselj-Strele, A; Linecker, A; Samonigg, H; Langner, C; Whiteside, TL
Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck.
Br J Cancer. 2011; 104(10):1641-1648
Doi: 10.1038/bjc.2011.131
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Heck, D; Menzel, C; Jakesz, R; Seifert, M; Hubalek, M; Pristauz, G; Bauernhofer, T; Eidtmann, H; Eiermann, W; Steger, G; Kwasny, W; Dubsky, P; Hochreiner, G; Forsthuber, EP; Fesl, C; Greil, R; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Lancet Oncol. 2011; 12(7):631-641
Doi: 10.1016/S1470-2045(11)70122-X
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Schneider, NI; Bauernhofer, T; Schöllnast, H; Ott, A; Langner, C
Pancreatic adenocarcinoma with multiple eosinophilic extracellular deposits consistent with noncalcified psammoma bodies.
Virchows Arch. 2011; 459(6):623-625
Doi: 10.1007/s00428-011-1159-x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
2010
Originalarbeit (Zeitschrift)
** Harbaum, L; Pollheimer, MJ; Bauernhofer, T; Kornprat, P; Lindtner, RA; Schlemmer, A; Rehak, P; Langner, C
Clinicopathological significance of prolactin receptor expression in colorectal carcinoma and corresponding metastases.
Mod Pathol. 2010; 23(7):961-971
Doi: 10.1038/modpathol.2010.83
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Stanzer, S; Janesch, B; Resel, M; Augustin, T; Samonigg, H; Bauernhofer, T
The role of activation-induced cell death in the higher onset of spontaneous apoptosis of NK cell subsets in patients with metastatic epithelial cancer.
Cell Immunol. 2010; 261(2):99-104
Doi: 10.1016/j.cellimm.2009.11.006
Web of Science
PubMed
FullText
FullText_MUG
** Symmans, WF; Hatzis, C; Sotiriou, C; Andre, F; Peintinger, F; Regitnig, P; Daxenbichler, G; Desmedt, C; Domont, J; Marth, C; Delaloge, S; Bauernhofer, T; Valero, V; Booser, DJ; Hortobagyi, GN; Pusztai, L
Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer.
J Clin Oncol. 2010; 28(27): 4111-4119.
Doi: 10.1200/JCO.2010.28.4273
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Ploner, F; Bauernhofer, T; Kasparek, AK; Payer, F; Balic, M; Knechtel, G; Gerger, A; Gallè, G; Samonigg, H; Hofmann, G
Paraneoplastic limbic encephalitis in a patient with extragonadal choriocarcinoma--significance of onconeural antibodies.
Onkologie. 2010; 33(8-9):452-454
Doi: 10.1159/000317269
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Wagner, V; Stadelmeyer, E; Riederer, M; Regitnig, P; Gorischek, A; Devaney, T; Schmidt, K; Tritthart, HA; Hirschberg, K; Bauernhofer, T; Schreibmayer, W
Cloning and characterisation of GIRK1 variants resulting from alternative RNA editing of the KCNJ3 gene transcript in a human breast cancer cell line.
J Cell Biochem. 2010; 110(3):598-608
Doi: 10.1002/jcb.22564
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Harbaum, L; Pollheimer, MJ; Bauernhofer, T; Kornprat, P; Lindtner, RA; Schlemmer, A; Rehak, P; Langner, C
Prolactin Receptor Expression in Colorectal Cancer Therapeutic Option for Affected Patients?
Ann Oncol 2010; 21, Supplement 1: i 30-i 30.-European Multidisciplinary Colorectal Cancer Congress; Mar 28-30, 2010; Nice, France.
[Poster]
Web of Science
** Harbaum, L; Pollheimer, MJ; Bauernhofer, T; Kornprat, P; Lindtner, RA; Schlemmer, A; Rehak, P; Langner, C
Prolactin Receptor Expression in Colorectal Cancer Therapeutic Option for Affected Patients?
Onkologie 2010; 33, Supplement 2: 63-63.-29. Deutscher Krebskongress; FEB 24-27, 2010; Berlin, Germany.
[Oral Communication]
Web of Science
2009
Originalarbeit (Zeitschrift)
** Filipits, M; Rudas, M; Heinzl, H; Jakesz, R; Kubista, E; Lax, S; Schippinger, W; Dietze, O; Greil, R; Stiglbauer, W; Kwasny, W; Nader, A; Stierer, M; Gnant, MF; Austrian Breast and Colorectal Cancer Study Group
Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.
Clin Cancer Res. 2009; 15(18):5888-5894
Doi: 10.1158/1078-0432.CCR-09-0728
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Pöstlberger, S; Menzel, C; Jakesz, R; Seifert, M; Hubalek, M; Bjelic-Radisic, V; Samonigg, H; Tausch, C; Eidtmann, H; Steger, G; Kwasny, W; Dubsky, P; Fridrik, M; Fitzal, F; Stierer, M; Rücklinger, E; Greil, R; ABCSG-12 Trial Investigators; Marth, C
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
N Engl J Med. 2009; 360(7):679-691
Doi: 10.1056/NEJMoa0806285
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Pichler, M; Balic, M; Stadelmeyer, E; Ausch, C; Wild, M; Guelly, C; Bauernhofer, T; Samonigg, H; Hoefler, G; Dandachi, N
Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors.
J Mol Diagn. 2009; 11(2):140-147
Doi: 10.2353/jmoldx.2009.080100
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Raml, R; Raber, G; Rumpler, A; Bauernhofer, T; Goessler, W; Francesconi, KA
Individual variability in the human metabolism of an arsenic-containing carbohydrate, 2',3'-dihydroxypropyl 5-deoxy-5-dimethylarsinoyl-beta-D-riboside, a naturally occurring arsenical in seafood.
Chem Res Toxicol. 2009; 22(9):1534-1540
Doi: 10.1021/tx900158h
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Loibner, H; Janzek, E; Peball, B; Schaefer, R; Schustet, M; Bauernhofer, T; Samonigg, H
Elevated Angiotensin II Levels in Plasma and Malignant Effusions of Cancer Patients: Recombinant Human ACE2 as Novel Biological Cancer Therapy
J IMMUNOTHER. 2009; 32(9):952-952.
[Poster]
Web of Science
** Poschl, EM; Wehr, E; Schweighofer, N; Pock, T; Bauernhofer, T; Obermayer-Pietsch, B
Bone metabolism markers in breast cancer-patients with and without bone metastases - Baseline data
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A19-A19.-ÖGIM; Linz, AUSTRIA.
[Poster]
Web of Science
2008
Originalarbeit (Zeitschrift)
** Dubsky, P; Sevelda, P; Jakesz, R; Hausmaninger, H; Samonigg, H; Seifert, M; Denison, U; Mlineritsch, B; Steger, G; Kwasny, W; Stöger, H; Bartsch, R; Stierer, M; Taucher, S; Fridrik, M; Schippinger, W; Greil, R; Pötter, R; Gnant, M; Austrian Breast and Colorectal Cancer Study Group
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Clin Cancer Res. 2008; 14(7):2082-2087
Doi: 10.1158/1078-0432.CCR-07-2068
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Gnant, M; Mlineritsch, B; Luschin-Ebengreuth, G; Kainberger, F; Kässmann, H; Piswanger-Sölkner, JC; Seifert, M; Ploner, F; Menzel, C; Dubsky, P; Fitzal, F; Bjelic-Radisic, V; Steger, G; Greil, R; Marth, C; Kubista, E; Samonigg, H; Wohlmuth, P; Mittlböck, M; Jakesz, R; Austrian Breast and Colorectal Cancer Study Group (ABCSG)
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
Lancet Oncol. 2008; 9(9):840-849
Doi: 10.1016/S1470-2045(08)70204-3
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Rudas, M; Lehnert, M; Huynh, A; Jakesz, R; Singer, C; Lax, S; Schippinger, W; Dietze, O; Greil, R; Stiglbauer, W; Kwasny, W; Grill, R; Stierer, M; Gnant, MF; Filipits, M; Austrian Breast and Colorectal Cancer Study Group
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
CLIN CANCER RES. 2008; 14(6): 1767-1774.
Doi: 10.1158/1078-0432.CCR-07-4122
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Stanzer, S; Dandachi, N; Balic, M; Resel, M; Samonigg, H; Bauernhofer, T
Resistance to apoptosis and expansion of regulatory T cells in relation to the detection of circulating tumor cells in patients with metastatic epithelial cancer.
J Clin Immunol. 2008; 28(2):107-114
Doi: 10.1007/s10875-007-9139-2
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Stefatic, D; Riederer, M; Balic, M; Dandachi, N; Stanzer, S; Janesch, B; Resel, M; Ler, D; Samonigg, H; Bauernhofer, T
Optimization of diagnostic ELISA-based tests for the detection of auto-antibodies against tumor antigens in human serum.
Bosn J Basic Med Sci. 2008; 8(3):245-250
Doi: 10.17305/bjbms.2008.2926
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Stanzer, S; Dandachi, N; Balic, M; Bauernhofer, T; Samonigg, H
The role of NKG2D expression and soluble MICA and MICB in the higher onset of apoptosis of NK cell subsets in patients with epithelial cancer
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A46-A46.
[Poster]
Web of Science
2007
Originalarbeit (Zeitschrift)
** Ausch, C; Dandachi, N; Buxhofer-Ausch, V; Balic, M; Huber, K; Bauernhofer, T; Ogris, E; Hinterberger, W; Braun, S; Schiessel, R
Immunomagnetic CD45 depletion does not improve cytokeratin 20 RT-PCR in colorectal cancer.
Clin Chem Lab Med. 2007; 45(3):351-356
Doi: 10.1515/CCLM.2007.059
Web of Science
PubMed
FullText
FullText_MUG
** Schippinger, W; Dandachi, N; Regitnig, P; Hofmann, G; Balic, M; Neumann, R; Samonigg, H; Bauernhofer, T
The predictive value of EGFR and HER-2/neu in tumor tissue and serum for response to anthracycline-based neoadjuvant chemotherapy of breast cancer.
Am J Clin Pathol. 2007; 128(4):630-637
Doi: 10.1309/51KPD70348RP6XTE
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Zeitschrift)
** Schippinger, W; Holub, R; Dandachi, N; Bauernhofer, T
Frequency of febrile neutropenia in patients treated with taxane/epirubicine and colony-stimulating growth factors for breast cancer: comparison of filgrastim/lenograstim with pegfilgrastim
BREAST CANCER RES. 2007; 9(1):
Doi: 10.1186/bcr1722
[Poster]
Web of Science
FullText
FullText_MUG
** Schippinger, W; Lileg, B; Ploner, F; Weitzer, W; Bauemhofer, T; Samonigg, H
Neoadjuvant chemotherapy with non-pegylated liposomal doxorubicin, docetaxel and trastuzumab in HER-2/neu overexpressing breast cancer
ANN ONCOL. 2007; 18: 166-166.
[Poster]
Web of Science
2006
Originalarbeit (Zeitschrift)
** Hofmann, G; Bauernhofer, T; Krippl, P; Lang-Loidolt, D; Horn, S; Goessler, W; Schippinger, W; Ploner, F; Stoeger, H; Samonigg, H
Plasmapheresis reverses all side-effects of a cisplatin overdose--a case report and treatment recommendation.
BMC Cancer. 2006; 6(2):1-1
Doi: 10.1186/1471-2407-6-1
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Klaritsch, P; Reich, O; Regauer, S; Bauernhofer, T
Recurrent endometrial stromal sarcoma after treatment with high-dose chemotherapy and autologous stem-cell support: A case report.
Eur J Gynaecol Oncol. 2006; 27(3):297-298
(- Case Report)
Web of Science
PubMed
** Liegl, B; Leithner, A; Bauernhofer, T; Windhager, R; Guelly, C; Regauer, S; Beham, A
Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours?
Histopathology. 2006; 49(6):576-581
Doi: 10.1111/j.1365-2559.2006.02562.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Schippinger, W; Holub, R; Dandachi, N; Bauernhofer, T; Samonigg, H
Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim.
Oncology. 2006; 70(4):290-293
Doi: 10.1159/000094890
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Schippinger, W; Regitnig, P; Dandachi, N; Wernecke, KD; Bauernhofer, T; Samonigg, H; Moinfar, F
Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer.
Virchows Arch. 2006; 449(1):24-30
Doi: 10.1007/s00428-006-0213-6
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Zeitschrift)
** Andritsch, E; Dietmaier, G; Bauernhofer, T; Samonigg, H
The influence of an artistic ward design on the wellbeing of cancer patients at the Division of Oncology at the Medical University of Graz
PSYCHO-ONCOL. 2006; 15(2):S71-S71.-8th World Congress of Psycho-Oncology; OCT 16-21, 2006; Ferrara-Venice, Italy.
[Poster]
Web of Science
** Andritsch, E; Ladinek, V; Zloklikovits, S; Stanzer, S; Bauernhofer, T
Identifying symptom burden and distress of cancer patients with chemotherapy: A pilot study for an Austrian sample
PSYCHO-ONCOL. ; 15(2):S158-S159.
[Poster]
Web of Science
** Andritsch, E; Ladinek, V; Zloklikovits, S; Stanzer, S; Bauernhofer, T
Psycho-neuro-immunology: Influence of psychosocial intervention on T and NK cell subsets in patients with breast cancer
PSYCHO-ONCOL. ; 15(2):S131-S131.-8th world congress of psycho-oncology; OCT 16-21, 2006; Ferrara-Venice, Italy.
[Poster]
Web of Science
** Bauernhofer, T; Samonigg, H; Regitnik, P; Lileg, B; Weizer, W; Waxenecker, G; Kainer, M; Wiederkum, S; Loibner, H; Kircheis, R
A phase I/II, open label trial of Lewis Y specific monoclonal antibody IGN311 to evaluate safety and efficacy in patients with malignant effusion.
J CLIN ONCOL. 24(18):111S-111S.-Asco-Meetung; 2.-6. Juni 2006; Atlanta/ Georgia, USA.
[Poster]
Web of Science
** Heller, A; Bauernhofer, T; N, N
An artist, an oncologist, a patient - a dialogue
PSYCHO-ONCOL. 2006; 15(2):S71-S72.-8th World Congress of Psych-Oncology; OCT 16-21, 2006; Ferrara-Venice, Italy.
[Oral Communication]
Web of Science
** Loibner, H; Bauernhofer, T; Samonigg, H; Regitnig, P; Weitzer, W; Lileg, B; Waxenecker, G; Kainer, M; Wiederkum, S; Schuster, M; Kircheis, R
A phase I/II, open label trial with the Lewis Y specific humanized monoclonal antibody IGN311 in patients with malignant effusions
J IMMUNOTHER. 29(6):634-634.-Meeting Society of Immunotherapy, 21st annual meeting; 26.-29. Oktober 2006; Los Angeles, USA.
[Poster]
Web of Science
2005
Originalarbeit (Zeitschrift)
** Balic, M; Dandachi, N; Hofmann, G; Samonigg, H; Loibner, H; Obwaller, A; van der Kooi, A; Tibbe, AG; Doyle, GV; Terstappen, LW; Bauernhofer, T
Comparison of two methods for enumerating circulating tumor cells in carcinoma patients.
Cytometry B Clin Cytom. 2005; 68(1):25-30
Doi: 10.1002/cyto.b.20065
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Bauernhofer, T; Zenahlik, S; Hofmann, G; Balic, M; Resel, M; Pirchmoser, R; Regitnig, P; Ambros, P; Dandachi, N; Samonigg, H
Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer.
Oncol Rep. 2005; 13(2):179-184
Web of Science
PubMed
FullText
Google Scholar
** Dandachi, N; Balic, M; Stanzer, S; Halm, M; Resel, M; Hinterleitner, TA; Samonigg, H; Bauernhofer, T
Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients.
J Mol Diagn. 2005; 7(5):631-637
Doi: 10.1016/S1525-1578(10)60597-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Szolar, DH; Korobkin, M; Reittner, P; Berghold, A; Bauernhofer, T; Trummer, H; Schoellnast, H; Preidler, KW; Samonigg, H
Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
RADIOLOGY. 2005; 234: 479-485.
Doi: 10.1148/radiol.2342031876
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Zeitschrift)
** Hofmann, G; Dandachi, N; Balic, M; Schippinger, W; Wernecke, KD; Samonigg, H; Bauernhofer, T
Quantitative measurement of soluble E-cadherin in sera of breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy and its predictive and prognostic value.
J CLIN ONCOL 2005 23: 70S-70S.
Web of Science
** Samonigg, H; Himmler, G; Gnant, M; Gastl, G; Loibner, H; Possinger, K; Bauernhofer, T; Dandachi, N; Balic, M; Steger, G; Obwaller, A
A multicenter phase II, open-label trial of multiple doses of cancer vaccine candidate IGN101 to evaluate efficacy against disseminated tumor cells in blood.
J CLIN ONCOL 2005 23: 180S-180S.
Web of Science
2004
Originalarbeit (Zeitschrift)
** Schippinger, W; Regitnig, P; Bauernhofer, T; Ploner, F; Hofmann, G; Krippl, P; Wehrschütz, M; Lax, S; Carney, W; Neumann, R; Wernecke, KD; Samonigg, H
The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer.
ONCOL REP. 2004; 11(6): 1331-1336.
Doi: 10.3892/or.11.6.1331
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Zeitschrift)
** Ludwig, H; Zojer, N; Linkesch, W; Kahls, P; Krieger, O; Greinix, HT; Hinterberger, W; Pittermann, E; Bauernhofer, T; Gastl, G
Results of autologous transplantation for multiple myeloma (MM) in Austria. An analysis based on data from the Austrian Stem Cell Transplantation (ASCT) Registry
J CLIN ONCOL 2004 22: 596S-596S.
Web of Science
2003
Originalarbeit (Zeitschrift)
** Bauernhofer, T; Eibl, M; Ploner, F; Kuss, I; Pfeifer, J; Sill, H; Samonigg, H
Acute pseudo-obstruction of the small intestine following high-dose chemotherapy and stem cell support.
Onkologie. 2003; 26(4):344-346
Doi: 10.1159/000072093
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Bauernhofer, T; Kuss, I; Friebe-Hoffmann, U; Baum, AS; Dworacki, G; Vonderhaar, BK; Whiteside, TL
Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer.
BRIT J CANCER. 2003; 88: 1301-1309.
Doi: 10.1038/sj.bjc.6600860
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bauernhofer, T; Kuss, I; Henderson, B; Baum, AS; Whiteside, TL
Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer.
EUR J IMMUNOL. 2003; 33: 119-124.
Doi: 10.1002/immu.200390014
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Obwaller, A; Balic, M; van der Kooi, A; Dandachi, N; Himmler, G; Mudde, GC; Peball, B; Grunt, S; Oberkleiner, P; Doyle, GV; Terstappen, LWMM; Bauernhofer, T; Samonigg, H; Loibner, H
Comparative analysis of three different methods for the detection of disseminated tumor cells
J IMMUNOTHER 2003 26: S49-S50.
Web of Science
** Samonigg, H; Hofmann, G; Bauernhofer, T; Balic, M; Stöger, H; Groiss, F; Himmler, G; Schuster, M; Rosenkaimer, F; Loibner, H
Phase if trial to explore the influence of concomitant chemotherapies on the immunogenicity of the cancer vaccine IGN101 in patients with epithelial cancers
J IMMUNOTHER 2003 26: S14-S14.
Web of Science
** Schippinger, W; Bauernhofer, T; Regitnig, P; Ploner, F; Krippl, P; Hofmann, G; Lax, S; Carney, W; Neumann, R; Wernecke, KD; Samonigg, H
Serum HER-2/neu dynamics in metastatic breast cancer as an independent prognostic factor.
BREAST CANCER RES TREAT 2003 82: S123-S123.
Web of Science
2002
Originalarbeit (Zeitschrift)
** Jakesz, R; Hausmaninger, H; Kubista, E; Gnant, M; Menzel, C; Bauernhofer, T; Seifert, M; Haider, K; Mlineritsch, B; Steindorfer, P; Kwasny, W; Fridrik, M; Steger, G; Wette, V; Samonigg, H; Austrian Breast and Colorectal Cancer Study Group Trial 5
Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5.
J CLIN ONCOL 2002 20: 4621-4627.
Doi: 10.1200%2FJCO.2002.09.112
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Zeitschrift)
** Schippinger, W; Bauernhofer, T; Ploner, F; Hofmann, G; Krippl, P; Neumann, R; Wernecke, KD; Samonigg, H
Serum HER-2/neu levels correlate with time to progression in therapy of metastatic breast cancer.
BREAST CANCER RES TREAT 2002 76: S104-S104.
Web of Science
1999
Originalarbeit (Zeitschrift)
** Samonigg, H; Wilders-Truschnig, M; Kuss, I; Plot, R; Stöger, H; Schmid, M; Bauernhofer, T; Tiran, A; Pieber, T; Havelec, L; Loibner, H
A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer.
J Immunother. 1999; 22(6):481-488
Doi: 10.1097/00002371-199911000-00002
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Übersichtsarbeit
** Bauernhofer, T; Stöger, H; Kasparek, AK; Ploner, F; Kuss, I; Pieber, TR; Kotz, R; Samonigg, H
Combined treatment of metastatic osteosarcoma of the spine.
Oncology. 1999; 57(4):265-268
Doi: 10.1159/000012058
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Bauernhofer, T; Schmid, M; Resel, M; Gilli, R; Halwachs, G; Lanzer, G; Wilders-Truschnig, M; Samonigg, H
Detection of minimal residual disease in bone marrow (BM) peripheral blood (PB) and apheresis products (AP) in metastatic breast cancer patients receiving sequential dose intensive chemotherapy with PBPC support.
BONE MARROW TRANSPLANT 1999 23: S145-S145.
Web of Science
** Bauernhofer, T; Schmid, M; Stoeger, H; Kasparek, AK; Ploner, F; Kuss, I; Gilli, R; Lanzer, H; Samonigg, H
Sequential dose intensive chemotherapy with cyclophosphamide and carboplatin (CC) with peripheral blood progenitor cell (PBPC) support in metastatic breast cancer patients.
BONE MARROW TRANSPLANT 1999 23: S37-S37.
Web of Science
** Samonigg, H; Kuss, I; Bauernhofer, T; Andritsch, E
The influence of an artistic design at an oncological ward on the patients' mood
PSYCHO-ONCOL 1999 8: 41-41.
Web of Science
** Schmid, M; Bauernhofer, T; Resel, M; Ploner, F; Schippinger, W; Gilli, R; Lanzer, G; Truschnig-Wilders, M; Samonigg, H
High-dose chemotherapy with peripheral blood stem cell support for high risk breast cancer.
BONE MARROW TRANSPLANT 1999 23: S42-S42.
Web of Science
1998
Originalarbeit (Zeitschrift)
** Lackner, C; Moser, R; Bauernhofer, T; Wilders-Truschnig, M; Samonigg, H; Berghold, A; Zatloukal, K
Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis.
Breast Cancer Res Treat. 1998; 47(1):29-40
Doi: 10.1023%2FA%3A1005913514376
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1996
Übersichtsarbeit
** Bauernhofer, T; Stöger, H; Schmid, M; Smola, M; Gürtl-Lackner, B; Höfler, G; Ranner, G; Reisinger, E; Samonigg, H
Sequential treatment of recurrent mesenteric desmoid tumor.
Cancer. 1996; 77(6):1061-1065
Doi: 10.1002/(SICI)1097-0142(19960315)77:6<1061::AID-CNCR9>3.0.CO;2-K
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
1995
Originalarbeit (Zeitschrift)
** Ludwig, H; Sundal, E; Pecherstorfer, M; Leitgeb, C; Bauernhofer, T; Beinhauer, A; Samonigg, H; Kappeler, AW; Fritz, E
Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
CANCER 1995 76: 2319-2329.
Doi: 10.1002/1097-0142(19951201)76:11<2319::AID-CNCR2820761121>3.0.CO;2-U
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Pakisch, B; Stöger, H; Poschauko, H; Samonigg, H; Bauernhofer, T; Pojer, E; Leitner, H; Stuecklschweiger, G; Peichl, KH; Quehenberger, F; Hackl, A
Treatment Results in Males with Breast-Cancer
EUROPEAN RADIOL. 1995; 5: 172-175.
Doi: 10.1007/BF00957114
Web of Science
FullText
FullText_MUG
Abstract (Zeitschrift)
** SAMONIGG, H; WILDERSTRUSCHNIG, M; KUSS, I; PLOT, R; STOGER, H; SCHMID, M; BAUERNHOFER, T; TIRAN, A; HAVELEC, L; LOIBNER, H
IMMUNIZATION WITH ANTIIDIOTYPE VACCINE SCV-106 PROLONGS SURVIVAL-TIME OF CANCER-PATIENTS WITH METASTATIC COLORECTAL-CANCER - A RANDOMIZED DOUBLE-BLIND CLINICAL-TRIAL
EUR J CANCER 1995 31A: 45-45.
Web of Science
1994
Originalarbeit (Zeitschrift)
** Stöger, H; Bauernhofer, T; Kasparek, AK; Schmid, M; Moser, R; Ploner, F; Derstvenscheg, E; Kuss, I; Wilders-Truschnig, M; Steindorfer, P
Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study.
Cancer Chemother Pharmacol. 1994; 34(1):75-78
Doi: 10.1007/BF00686116
Web of Science
PubMed
FullText
FullText_MUG
** Stöger, H; Bauernhofer, T; Moser, R; Derstvenscheg, E; Schmid, M; Ploner, F; Pakisch, B; Wilders-Truschnig, M; Haas, J; Steindorfer, P
Breast cancer in the man: a report of 30 patients].
Wien Klin Wochenschr. 1994; 106(18):575-580
Web of Science
PubMed
Google Scholar
** Stöger, H; Bauernhofer, T; Schmid, M; Ploner, F; Moser, R; Derstvenscheg, E; Steindorfer, P; Wilders-Truschnig, M; Kuss, I; Samonigg, H
A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients.
Cancer Chemother Pharmacol. 1994; 35(2):174-178
Doi: 10.1007/BF00686643
Web of Science
PubMed
FullText
FullText_MUG
** Stöger, H; Schmid, M; Bauernhofer, T; Moser, R; Ploner, F; Derstvenscheg, E; Kasparek, AK; Kuss, I; Wilders-Truschnig, M; Lackner, C
A phase II trial of weekly high-dose folinic acid and 5-fluorouracil in combination with epirubicin as salvage chemotherapy in advanced breast cancer.
Oncology. 1994; 51(6):518-522
Doi: 10.1159/000227397
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1993
Originalarbeit (Zeitschrift)
** Stöger, H; Wilders-Truschnig, M; Samonigg, H; Schmid, M; Bauernhofer, T; Tiran, A; Tas, M; Drexhage, HA
The presence of immunosuppressive 'p15E-like' factors in the serum and urine of patients suffering from malign and benign breast tumours.
Clin Exp Immunol. 1993; 93(3):437-441
Doi: 10.1111/j.1365-2249.1993.tb08197.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1990
Originalarbeit (Zeitschrift)
** Samonigg, H; Stöger, H; Bauernhofer, T; Schmid, M; Kasparek, AK; Kuss, I; Kaul, M; Heberle, U; Vieder, L; Dusleag, J
Combination therapy of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose folinic acid in patients with advanced breast cancer: a phase I-II study (preliminary results).
Am J Clin Oncol. 1990; 13 Suppl 1(4):S44-S47
Doi: 10.1097/00000421-199012001-00010
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar